Timoptola 0.25 %. Timoptola 0.5 % 2.5 mg/ 5.0 mg Ophthalmic Solution
PDF Leaflet Revision Date: 11 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of elevated intraocular pressure in glaucoma and ocular hypertension.
Dosage (summary)
1 drop of 0.25% solution twice daily; may increase to 0.5% if needed.
Onset of Action / Duration
Onset: 20 mins, Duration: up to 24 hours
Special Populations
- Paediatric patients
- Elderly patients
Pregnancy & Breastfeeding
Not recommended in pregnancy; detectable in breast milk.
Key Drug Interactions
- CYP2D6 inhibitors
- Calcium channel blockers
- Digitalis glycosides
Contraindications
- Sinus bradycardia
- Asthma
- Cardiac failure
Common side effects
- Ocular irritation
- Dizziness
- Bradycardia
Counselling Points
- Monitor for respiratory symptoms
- Avoid contact lenses during use
- Report any adverse reactions
Serious warnings
- Caution in respiratory diseases
- Potential for systemic absorption
Important Disclaimer
The Timoptola 0.25 %. Timoptola 0.5 % 2.5 mg/ 5.0 mg Ophthalmic Solution professional information leaflet below is the property of Mundipharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
